Month: August 2021
9M 2020/21Interim financial results, 9M 2020/211 October 2020 – 30 June 2021
Coloplast delivered Q3 organic growth of 11% and 33% EBIT margin. Financial guidance narrowedColoplast delivered 11% organic growth in Q3. Reported revenue in DKK was up by 9% to DKK 4,835 million. Organic growth rates by business area in Q3: Ostomy Care 4%, Continence Care 5%, Interventional Urology 82% and Wound & Skin Care 17%.
The Chronic Care business was positively impacted by improving underlying growth in Europe as well as a lower baseline. Growth was partly offset by lower growth in new patients in the US due to COVID-19, in especially Continence Care, as well as distributor destocking due to a prolonged period of lower growth in new patients. Ostomy Care delivered a softer quarter in Emerging markets due to tender phasing in the Middle...
Awilco Drilling PLC: Q2 2021 Presentation
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Please find attached the Q2 2021 presentation held in the digital meeting today.
Aberdeen, 18 August 2021
For further information please contact:
Eric Jacobs, Interim CEOPhone: +44 1224 737900
Cathrine Haavind, Investor RelationsPhone: +47 93 42 84 64Email: ch@awilcodrilling.com
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
AttachmentAWDR Q2 2021 pres
Medallion Resources Adds Daniel Mamadou and Gabriel Alonso-Mendoza to Board
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”), is pleased to announce the addition of Daniel Mamadou and Gabriel Alonso-Mendoza to the Board of Directors (the “Board”). Both Daniel and Gabriel are long term, active participants and investors in the rare earth element industry, and bring extensive commercial and financial experience to the Medallion team.
“The addition of Daniel Mamadou and Gabriel Alonso-Mendoza to the Medallion Board is a key moment for the Company, providing a new level of financial and commercial capacity” said Mark Saxon, President and CEO. “Both Daniel and Gabriel have impressive records, and their contributions to Medallion’s strategy and growth are highly anticipated.”
Daniel Mamadou is the...
Huize Partners with Sun Life Everbright Life Insurance to Launch “Everbright Smart Choice” – A Customized Retirement Annuity Insurance Product
Written by Customer Service on . Posted in Public Companies.
SHENZHEN, China, Aug. 18, 2021 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that it has partnered with Sun Life Everbright Life Insurance Company (“Sun Life Everbright”) to launch “Everbright Smart Choice”, a customized retirement annuity insurance product dedicated to meet customers’ multi-dimensional needs for both wealth accumulation and lifetime pension benefits.
There are three key product highlights to the “Everbright Smart Choice” offering: (i) high flexibility on premium payment terms and annuity payout options; (ii) a lifetime annuity income stream with a high cash value; and (iii) the option to get access to the Sun Life Everbright universal account with a...
Opendoor Technologies Inc. Prices Upsized $850 Million Convertible Senior Notes Offering
Written by Customer Service on . Posted in Public Companies.
SAN FRANCISCO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN) (“Opendoor”), a leading digital platform for residential real estate, today announced the pricing of its offering of $850,000,000 aggregate principal amount of 0.25% convertible senior notes due 2026 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $750,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on August 20, 2021, subject to customary closing conditions. Opendoor also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including,...
Li Auto Inc. to Report Second Quarter 2021 Financial Results on August 30, 2021
Written by Customer Service on . Posted in Public Companies.
BEIJING, China, Aug. 18, 2021 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), an innovator in China’s new energy vehicle market, today announced that it will report its unaudited financial results for the second quarter of 2021 before the U.S. market opens on Monday, August 30, 2021.
The Company’s management will hold an earnings conference call on Monday, August 30, 2021, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing Time on the same day.
For participants who wish to join the call, please complete online registration using the link provided below at least 20 minutes prior to the scheduled call start time. Upon registration, participants will receive the conference call access information, including dial-in numbers, Direct Event passcode, a unique registrant ID and an e-mail with detailed...
Juva Life Announces Top Line R/D Data and Initiates Optimization & Development of Juva-019
Written by Customer Service on . Posted in Public Companies.
–Company identifies Non-Cannabinoid Anti-Inflammatory Compounds Suitable for Drug and Consumer Product Development
VANCOUVER, British Columbia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California based life sciences company focused on the research, development, and commercialization of Cannabis products today announced initial pre-clinical discovery results from the phenotypic screening and target profiling of its proprietary cannabis chemical library. The initial results of this effort have identified Juva-019 which has been nominated for development.
Juva-019 is a non-cannabinoid purified small molecule isolated from Cannabis with broad spectrum anti-inflammatory properties. Juva-019 is potent modulator of TNF-alpha, IL-1 beta,...
UCLOUDLINK GROUP INC. to Report Second Quarter 2021 Financial Results on August 25, 2021
Written by Customer Service on . Posted in Public Companies.
Earnings Call Scheduled for 8:00 a.m. Eastern Time on August 25, 2021
HONG KONG, Aug. 18, 2021 (GLOBE NEWSWIRE) — UCLOUDLINK GROUP INC. (“uCloudlink” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced that it will report its second quarter 2021 unaudited financial results before the market open on Wednesday, August 25, 2021.
Management will hold a conference call at 8:00 a.m. Eastern Time on Wednesday, August 25, 2021 (8:00 p.m. Beijing Time on August 25, 2021). Listeners may access the call by dialing:International:
+1-412-902-4272US (Toll Free):
+1-888-346-8982UK (Toll Free):
0-800-279-9489UK (Local Toll):
0-207-544-1375Mainland China (Toll Free):
400-120-1203Hong Kong (Toll Free):
800-905-945Hong Kong (Local Toll):
+852-3018-4992Singapore...
Result of the auction of 0.00 per cent DGB 2024, 0.00 per cent DGB 2031 and 0.25 per cent DGB 2052
Written by Customer Service on . Posted in Public Companies.
Bids, sales, cut-off price, pro rata and yield are presented in the table below: ISIN
Bid mill. DKK (nominal)
Sale mill.DKK (nominal)
Cut-off price
Pro rata
Yield99 24292 DGB 0.00% 15/11/2024
40
0
–
–
–99 24102 DGB 0.00% 15/11/2031
3,960
3,180
101.70
100 %
-0.16 % p.a.99 24029 DGB 0.25% 15/11/2052
1,740
1,000
100.69
100 %
0.23 % p.a.Total
5,740
4,180
Settlement: 20 August 2021
Cholesterol Lowering Drugs Market Report 2021-2028| Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast
Written by Customer Service on . Posted in Mergers And Acquisitions.
Top Players Covered in the Cholesterol Lowering Drugs Market Research Report Are AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Sun Pharmaceuticals Industries Ltd., Sanofi, Merck & Co., Amgen Inc., Dr. Reddy’s and other key market players.
Pune, India, Aug. 18, 2021 (GLOBE NEWSWIRE) — The global Cholesterol Lowering Drugs Market size is expected to gain momentum owing to the increasing geriatric population during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, “Cholesterol Lowering Drugs Market, 2021-2028.” The advent of new medicine classes, changes in lifestyles, a lack of exercise, and an increase in saturated and trans-fat intake are expected to fuel the rise of the cholesterol-lowering drug industry. Furthermore, an increase in smoking and alcohol intake...
